Cargando…

Effects of the Addition of Hiltonol(®) (Poly-ICLC) to a SARS-CoV S Protein Vaccine in Lethal SARS-CoV Mouse Model

Detalles Bibliográficos
Autores principales: Barnard, Dale L., Wandersee, Miles, Bailey, Kevin, Smith, Aaron, Vest, Zach, Morrey, John D., Salazar, Andres M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier B.V. 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7133864/
http://dx.doi.org/10.1016/j.antiviral.2011.03.022
_version_ 1783517711572140032
author Barnard, Dale L.
Wandersee, Miles
Bailey, Kevin
Smith, Aaron
Vest, Zach
Morrey, John D.
Salazar, Andres M.
author_facet Barnard, Dale L.
Wandersee, Miles
Bailey, Kevin
Smith, Aaron
Vest, Zach
Morrey, John D.
Salazar, Andres M.
author_sort Barnard, Dale L.
collection PubMed
description
format Online
Article
Text
id pubmed-7133864
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-71338642020-04-08 Effects of the Addition of Hiltonol(®) (Poly-ICLC) to a SARS-CoV S Protein Vaccine in Lethal SARS-CoV Mouse Model Barnard, Dale L. Wandersee, Miles Bailey, Kevin Smith, Aaron Vest, Zach Morrey, John D. Salazar, Andres M. Antiviral Res Article Published by Elsevier B.V. 2011-05 2011-05-08 /pmc/articles/PMC7133864/ http://dx.doi.org/10.1016/j.antiviral.2011.03.022 Text en Copyright © 2011 Published by Elsevier B.V. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Barnard, Dale L.
Wandersee, Miles
Bailey, Kevin
Smith, Aaron
Vest, Zach
Morrey, John D.
Salazar, Andres M.
Effects of the Addition of Hiltonol(®) (Poly-ICLC) to a SARS-CoV S Protein Vaccine in Lethal SARS-CoV Mouse Model
title Effects of the Addition of Hiltonol(®) (Poly-ICLC) to a SARS-CoV S Protein Vaccine in Lethal SARS-CoV Mouse Model
title_full Effects of the Addition of Hiltonol(®) (Poly-ICLC) to a SARS-CoV S Protein Vaccine in Lethal SARS-CoV Mouse Model
title_fullStr Effects of the Addition of Hiltonol(®) (Poly-ICLC) to a SARS-CoV S Protein Vaccine in Lethal SARS-CoV Mouse Model
title_full_unstemmed Effects of the Addition of Hiltonol(®) (Poly-ICLC) to a SARS-CoV S Protein Vaccine in Lethal SARS-CoV Mouse Model
title_short Effects of the Addition of Hiltonol(®) (Poly-ICLC) to a SARS-CoV S Protein Vaccine in Lethal SARS-CoV Mouse Model
title_sort effects of the addition of hiltonol(®) (poly-iclc) to a sars-cov s protein vaccine in lethal sars-cov mouse model
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7133864/
http://dx.doi.org/10.1016/j.antiviral.2011.03.022
work_keys_str_mv AT barnarddalel effectsoftheadditionofhiltonolpolyiclctoasarscovsproteinvaccineinlethalsarscovmousemodel
AT wanderseemiles effectsoftheadditionofhiltonolpolyiclctoasarscovsproteinvaccineinlethalsarscovmousemodel
AT baileykevin effectsoftheadditionofhiltonolpolyiclctoasarscovsproteinvaccineinlethalsarscovmousemodel
AT smithaaron effectsoftheadditionofhiltonolpolyiclctoasarscovsproteinvaccineinlethalsarscovmousemodel
AT vestzach effectsoftheadditionofhiltonolpolyiclctoasarscovsproteinvaccineinlethalsarscovmousemodel
AT morreyjohnd effectsoftheadditionofhiltonolpolyiclctoasarscovsproteinvaccineinlethalsarscovmousemodel
AT salazarandresm effectsoftheadditionofhiltonolpolyiclctoasarscovsproteinvaccineinlethalsarscovmousemodel